Alyn McNaughton

Title: Alyn McNaughton: Innovator in Pharmaceutical Compositions

Introduction

Alyn McNaughton is a notable inventor based in West Lothian, GB. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on formulations that utilize oxidized phospholipids. His work is aimed at addressing inflammatory disorders through innovative drug delivery systems.

Latest Patents

Alyn McNaughton holds a patent for "Formulations and dosage forms of oxidized phospholipids." This patent includes pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4'-carboxybutyl)-glycero-3-phosphocholine (VB-201), combined with a thermosoftening carrier like a poloxamer. The compositions may also include an anti-adherent agent, such as talc, and/or a thixotropic agent. Additionally, the patent outlines processes for preparing these pharmaceutical compositions and describes capsules that contain them. The uses of these compositions and capsules in treating inflammatory disorders are also detailed in the patent.

Career Highlights

Alyn McNaughton has been instrumental in advancing pharmaceutical technology through his innovative research and development efforts. His work has led to the creation of effective formulations that have the potential to improve treatment outcomes for patients suffering from inflammatory conditions.

Collaborations

Alyn collaborates with talented professionals in his field, including Naamit Sher and Victor M Young. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Alyn McNaughton's contributions to pharmaceutical compositions highlight his role as a key innovator in the industry. His patent on oxidized phospholipids showcases his commitment to developing effective treatments for inflammatory disorders.